Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.
about
From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentPharmacogenetics of erectile dysfunction: navigating into uncharted watersSexual Function Across Aging.Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate.Antidepressants and sexual dysfunction: mechanisms and clinical implications.Sexual dysfunction associated with major depressive disorder and antidepressant treatment.A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinitiesPharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project data.A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual menPharmacogenetics of antidepressant response.Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period.Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Study of effects of selective serotonin reuptake inhibitors on stages of sexual function in Iranian patients with major depressive disorder.Pharmacogenetics of antidepressantsShared genetic background for regulation of mood and sleep: association of GRIA3 with sleep duration in healthy Finnish women.The promise and reality of pharmacogenetics in psychiatryGenetic variability in the NMDA-dependent AMPA trafficking cascade is associated with alcohol dependenceActivation of NMDA receptors in lumbar spinothalamic cells is required for ejaculation.Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.Major depressive disorder: new clinical, neurobiological, and treatment perspectives.Pharmacogenetics of glutamate system genes and SSRI-associated sexual dysfunction.Pharmacogenetics studies in STAR*D: strengths, limitations, and resultsPharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.Pharmacogenetic considerations in the treatment of psychiatric disorders.Personalized medicine for depression: can we match patients with treatments?Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Pharmacogenomics and sexuality: a vision.Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.Patterned expression of ion channel genes in mouse dorsal raphe nucleus determined with the Allen Mouse Brain Atlas.BDNF-GSK-3β-β-Catenin Pathway in the mPFC Is Involved in Antidepressant-Like Effects of Morinda officinalis Oligosaccharides in Rats.Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunction.Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment.Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.Pharmacogenetics of SSRIs and Sexual Dysfunction.
P2860
Q27015830-5BE86DF6-FB92-4C0C-8ACB-CC32AB70FCF7Q28249515-A2A42ABA-504C-418E-9D90-A702AE121FFBQ30277641-DFEBD728-B15C-4E8F-985A-0474E346251BQ30457019-D8EA9275-73DA-48D1-9EE5-D77F9AFECFC3Q30457744-D0BD4AED-6508-4FA8-BB02-2CE1A819D263Q30458935-9F5B6428-FBEE-48E5-BF5A-1B7B3FC0C62CQ30657759-E72AA662-1FB5-43DE-9C91-D673998E69F3Q30863802-7E24DC6B-CDC4-47D6-AB0E-3500A9BB0184Q34038361-13A79EC2-E2EA-46AC-9040-F77BEDC5E3BFQ34155796-36DEFA1C-FDA2-48CC-AF8F-C7B18A72E035Q34236311-CCADA91E-5CF4-4C8B-A296-BA630D8F5CBCQ34424865-BCF71B43-EC88-405D-BCC9-0F3B9CD48115Q34658064-5DAF158C-67F6-4F4D-BFA1-5FB9A941D101Q35026088-4E45FD22-44EC-49FA-9F5E-08017AC64109Q35217752-0DF7C497-4152-48A9-9505-051227C3AF2CQ35226451-402D6570-596C-4470-A84E-E1A9C53B9010Q35403595-D7DC25BF-F788-4DC7-BE21-E56F1BDBFE32Q35659616-ED76D365-1AF5-41F5-A25F-245B43CC4866Q35755912-9C0AC442-4E81-4ED0-A368-3EAD81122E22Q36096664-69E24879-7E71-4C64-992F-DA42BC5C7CE0Q36279178-1BD811A2-6930-4091-A204-A3D7F388DE38Q37178537-2F6B846A-9FF6-4F00-9DEB-9368DC216C62Q37618221-ED089651-0566-4234-B62A-2BB521111F08Q37681573-89358036-1030-4027-B05B-B49D2BA79207Q37789098-E43CA110-6C85-4F24-9ED3-58004ED6E283Q37989490-A304F158-C40F-49B5-B456-C5C88AC31784Q38121154-3410B963-3A07-4AAA-A37A-D3FB59367AC2Q38121519-967F8A85-BED4-44A7-BBDF-7F8B140B8A32Q39216998-F8CDFA82-14E9-48B9-A7D5-48CCB10570F2Q39298316-8F9F5D57-9512-4770-8323-7AF7E666972BQ48155028-67875EF5-8784-4CFB-B87E-D55EE91F495EQ48311592-6A66616C-9EE3-4921-A4BA-4DC592DAE4ECQ48372657-981D4258-0D7D-4BC7-A41A-83EAB3D663CFQ55506542-13E84226-AD45-4767-9FA7-3ABA8EACD540
P2860
Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Genetic and clinical predictor ...... am-treated depressed patients.
@en
Genetic and clinical predictor ...... am-treated depressed patients.
@nl
type
label
Genetic and clinical predictor ...... am-treated depressed patients.
@en
Genetic and clinical predictor ...... am-treated depressed patients.
@nl
prefLabel
Genetic and clinical predictor ...... am-treated depressed patients.
@en
Genetic and clinical predictor ...... am-treated depressed patients.
@nl
P2093
P2860
P356
P1476
Genetic and clinical predictor ...... am-treated depressed patients.
@en
P2093
A John Rush
Gonzalo Laje
Jordan W Smoller
Maurizio Fava
Roy H Perlis
P2860
P2888
P304
P356
10.1038/NPP.2009.4
P407
P577
2009-03-18T00:00:00Z
P5875
P6179
1015515596